This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Endocrinology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 114 No. 1 July 2004, pp. 259-263


COMMENTARY

An Update on Type 2 Diabetes in Youth From the National Diabetes Education Program

Diabetes in Children Adolescents Work Group of the National Diabetes Education Program

Abbreviations: AAP, American Academy of Pediatrics • ADA, American Diabetes Association • NDEP, National Diabetes Education Program • NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases • CDC, Centers for Disease Control and Prevention • BMI, body mass index • LDL, low-density lipoprotein

The first 300 words of the full text of this article appear below.

In the year 2000, the American Academy of Pediatrics (AAP) and American Diabetes Association (ADA) issued a joint consensus statement on type 2 diabetes in children and adolescents.1,2 The statement presented current knowledge concerning the classification, epidemiology, and pathophysiology of type 2 diabetes in youth and provided management guidance for providers concerning testing, treating, and preventing this serious and costly disease. Because it is clear that glucose intolerance develops on a continuum from normal blood glucose to frank type 2 diabetes in children and adults, early interventions in this process may effectively reduce risk for diabetes complications.

This commentary provides an update for pediatric health care providers on new research findings, the costs related to obesity and diabetes, and gains made in national initiatives focused on youth with or at risk for type 2 diabetes. A goal of the National Diabetes Education Program (NDEP) is to assist health care providers and consumers to better meet the needs of children with or at risk for type 2 diabetes. NDEP is jointly sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Centers for Disease Control and Prevention (CDC) and works in partnership with >200 professional and consumer organizations including the AAP, ADA, and Juvenile Diabetes Research Foundation International.


    PREVALENCE ESTIMATES
 
True population-based prevalence data are not available yet, but existing statistics indicate that the prevalence of type 2 diabetes in youth is increasing. Although no ethnic group is free of the problem, the disease disproportionately affects American Indian, African American, Mexican American, and Pacific Islander youth.3–5 In 15- to 19-year-old Pima Indians of Arizona, the prevalence of type 2 diabetes is 5%.3 In several clinic-based studies, the percentage of children with newly diagnosed diabetes who are classified as having type 2 diabetes has risen from <5% before 1994 . . . [Full Text of this Article]

Reprint requests to National IHS Diabetes Program, 5300 Homestead Rd NE, Albuquerque, NM 87110. E-mail: kelly.moore@mail.ihs.gov


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The Journal of School NursingHome page
L. H. Jones and M. Ficca
Is Acanthosis Nigricans a Reliable Indicator for Risk of Type 2 Diabetes?
The Journal of School Nursing, October 1, 2007; 23(5): 247 - 251.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
P. A. Estabrooks and S. Shetterly
The Prevalence and Health Care Use of Overweight Children in an Integrated Health Care System
Arch Pediatr Adolesc Med, March 1, 2007; 161(3): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
M. Somorai, C. Giambruno, and T. Abdelmoneim
Index of Suspicion in the Nursery
NeoReviews, July 1, 2006; 7(7): e370 - e373.
[Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. L. Christensen, B. Meibohm, E. V. Capparelli, P. Velasquez-Mieyer, G. A. Burghen, and W. V. Tamborlane
Single- and Multiple-Dose Pharmacokinetics of Pioglitazone in Adolescents With Type 2 Diabetes
J. Clin. Pharmacol., October 1, 2005; 45(10): 1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
B. Schreiner
Promoting Lifestyle and Behavior Change in Overweight Children and Adolescents With Type 2 Diabetes
Diabetes Spectr, January 1, 2005; 18(1): 9 - 12.
[Full Text] [PDF]